[18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease (scientific article published in February 2001)

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Q27860795

Statistical parametric maps in functional imaging: A general linear approach

Q27864122

Diagnosing dementia with Lewy bodies

Q33751527

Cholinesterase inhibitors: A new class of psychotropic compounds

Q33807472

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

Q34736093

Diffuse Lewy body disease in Japan

Q37941288

Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease

Q41354157

Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease

Q42458585

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease

Q43770335

Autosomal dominant Lewy body parkinsonism in a four-generation family

Q46179622

Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies

Q48392838

Performance evaluation of a large axial field-of-view PET scanner: SET-2400W.

Q48538636

Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease.

Q53222178

Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies.

Q53335020

Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

Q53340013

Spatial registration and normalization of images

Q57004421

Clinical features of familial diffuse Lewy body disease

Q67218945

Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.

Q67234444

P433

issue

P921

main subject

dementia

Q83030

Alzheimer's disease

Q11081

dementia with Lewy bodies

Q101245788

P304

page(s)

447-456

P577

publication date

2001-02-01

P1433

published in

Progress in Neuro-Psychopharmacology & Biological Psychiatry

Q15616665

P1476

title

[18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease

P478

volume

Reverse relations

cites work (P2860)

Q34113084	(99m)Tc-hexamethyl propyleneamine oxime brain perfusion single photon emission computed tomography in characterization of dementia: an initial experience in Indian clinical practice
Q31033082	Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia
Q43233891	Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.
Q37756103	Autopsy as gold standard in FDG-PET studies in dementia.
Q39440179	Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Q53513882	Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.
Q53269086	Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT.
Q37329050	Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study
Q35692950	Imaging Alzheimer's disease: clinical applications
Q48189574	Metabolic correlates of brain reserve in dementia with Lewy bodies: an FDG PET study.
Q64446743	Neuroimaging in Dementia
Q30756562	Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology
Q57813333	The relationship between hallucinations and FDG-PET in dementia with Lewy bodies
Q51906039	Utility of the Bender Gestalt Test for differentiation of dementia with Lewy bodies from Alzheimer's disease in patients showing mild to moderate dementia.
Q50725111	Verbal and nonverbal learning and recall in dementia with lewy bodies and Alzheimer's disease.
Q31108303	[Molecular imaging in neurological diseases].

P356	DOI	10.1016/S0278-5846(01)80005-1
P698	PubMed publication ID	11294488